NLS Pharmaceutics Ltd.NLS Pharmaceutics Ltd.NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd.

No trades
See on Supercharts
Market capitalization
‪5.25 M‬USD
‪−16.50 M‬USD
‪21.84 M‬
Beta (1Y)
0.73

About NLS Pharmaceutics Ltd.

CEO
Alexander Zwyer
Headquarters
Zurich
Employees (FY)
2
Founded
2015
ISIN
CH0523961370
FIGI
BBG00S2L23F4
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NLSP is 0.1299 USD — it has decreased by 2.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NLS Pharmaceutics Ltd. stocks are traded under the ticker NLSP.
NLS Pharmaceutics Ltd. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
NLSP stock is 23.01% volatile and has beta coefficient of 0.73. Check out the list of the most volatile stocks — is NLS Pharmaceutics Ltd. there?
NLSP earnings for the last quarter are −0.31 USD per share, whereas the estimation was −0.35 USD resulting in a 10.14% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about NLS Pharmaceutics Ltd. earnings.
Yes, you can track NLS Pharmaceutics Ltd. financials in yearly and quarterly reports right on TradingView.
NLSP stock has fallen by 9.79% compared to the previous week, the month change is a 22.22% fall, over the last year NLS Pharmaceutics Ltd. has showed a 91.34% decrease.
Today NLS Pharmaceutics Ltd. has the market capitalization of ‪5.14 M‬, it has decreased by 2.98% over the last week.
No, NLSP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NLSP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NLS Pharmaceutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
NLSP reached its all-time high on Mar 12, 2021 with the price of 7.3500 USD, and its all-time low was 0.1311 USD and was reached on Apr 16, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 2.00 employees. See our rating of the largest employees — is NLS Pharmaceutics Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NLS Pharmaceutics Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NLS Pharmaceutics Ltd. stock shows the strong sell signal. See more of NLS Pharmaceutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.